Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. jury's mixed Theranos verdict complicates Holmes' potential appeal -experts

Published 01/04/2022, 02:44 PM
Updated 01/04/2022, 06:41 PM
© Reuters. Theranos founder Elizabeth Holmes and her family leave the federal court after a U.S. jury found Holmes guilty in her fraud trial, in San Jose, California, U.S. January 3, 2022. REUTERS/Brittany Hosea-Small

By Jody Godoy

(Reuters) - Theranos founder Elizabeth Holmes is likely to appeal her conviction for defrauding investors in the blood-testing company, but four legal experts say the fact that the jury acquitted her or failed to reach a verdict on several counts could work against her.

Holmes on Monday was found guilty https://www.reuters.com/world/us/us-jury-theranos-trial-cannot-agree-verdicts-all-charges-2022-01-03 of defrauding investors in the once high-flying Silicon Valley blood-testing startup, but she was acquitted of deceiving patients. The guilty verdict on four of 11 counts came after a months-long trial https://www.reuters.com/world/us/rise-fall-theranos-founder-elizabeth-holmes-2022-01-04.

A jury found the former Silicon Valley entrepreneur guilty of conspiring to dupe investors and of defrauding three private investors. The jury deadlocked on charges related to other investors, and acquitted Holmes of swindling patients.

Holmes' lawyers have not yet said whether she would appeal. Attorneys for Holmes did not respond to a request for comment on Tuesday.

Legal experts not involved in the case said that the fact jurors found in Holmes' favor on some charges will weaken arguments that they were confused or biased.

"In a mixed verdict, it's very hard to say that the jury rushed to judgment," said Carrie Cohen, a white-collar defense attorney and former prosecutor in New York. "It appears that they didn't take evidence from one crime and use it to say, 'Well, she lied to one investor. She must have lied to the three other investors.'"

The experts said a likely focus of an appeal would be rulings made by U.S. District Judge Edward Davila in favor of prosecutors during or before the trial, such as allowing jurors to see a regulatory report from 2015 saying that the conditions in Theranos' lab posed "immediate jeopardy to patient health and safety."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Her attorneys had challenged prosecutors' use of the report, arguing it was irrelevant and would unfairly prejudice jurors against Holmes. The judge found that the evidence could be used to show that Holmes was aware of problems at Theranos.

The report was among the evidence introduced during the testimony of 29 government witnesses.

But appeals courts are hesitant to disturb jury verdicts, and would consider whether any erroneous ruling was significant enough to have impacted the result, said Vanderbilt Law School professor Christopher Slobogin.

Another focus for a potential appeal would be the instructions the jury received before deliberations, including on the meaning of "reasonable doubt." The judge denied Holmes' call for further instructions on that legal standard, which sets a high bar for conviction in criminal cases.

In the United States, criminal defendants are presumed innocent unless proven guilty beyond a reasonable doubt.

Cohen said that arguing the jury was confused about the standard may be an "uphill battle" since it decided to acquit on some counts.

But the mixed verdict may prove helpful at Holmes' sentencing, said Amanda Kramer, a partner at Covington & Burling.

Holmes' attorneys will likely argue that her conviction on only some of the counts after a nearly four-month trial shows "she wasn't some snake oil salesperson out there just trying to rip people off."

"The defense will argue to the judge that that's really meaningful, that she stands apart from the predatory fraudsters that are found guilty across the board," Kramer said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.